Journal of Multiple Sclerosis

A Novel Synthetic Peptide is Reviewed

Adam Hoffman*

DOI: 10.35248/2376-0389.22.9.07.453

A Potential Clinical Index for Parkinson's Disease Using Human Brain Magnetic Resonance Imaging

Adam Hoffman*

DOI: 10.35248/2376-0389.22.9.07.455

A Review of Olfactory Dysfunction and Neurological Disorders

Maria Richards*

Two-year Assessment of the Efficacy and Safety of Ocrelizumab in Switching Patients from Other Disease Modifying Therapies

Terzi Murat, Boz Cavit, Demir Caner Feyz, Cilingir Vedat* and Helvaci Elif Merve

DOI: 10.35248/2376-0389.22.9.12.475

Neuroinflammation in Parkinson’s disease (PD)

Elyna Joy*

DOI: 10.35248/2376 0389.22.9.12.478